{"id":"https://openalex.org/W4282928855","doi":"https://doi.org/10.36849/jdd.6778","title":"Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream","display_name":"Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream","publication_year":2022,"publication_date":"2022-05-01","ids":{"openalex":"https://openalex.org/W4282928855","doi":"https://doi.org/10.36849/jdd.6778","pmid":"https://pubmed.ncbi.nlm.nih.gov/35674762"},"language":"en","primary_location":{"id":"doi:10.36849/jdd.6778","doi":"https://doi.org/10.36849/jdd.6778","is_oa":false,"landing_page_url":"https://doi.org/10.36849/jdd.6778","pdf_url":null,"source":{"id":"https://openalex.org/S111565304","display_name":"Journal of Drugs in Dermatology","issn_l":"1545-9616","issn":["1545-9616"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4323285840","host_organization_name":"SanovaWorks","host_organization_lineage":["https://openalex.org/P4323285840"],"host_organization_lineage_names":["SanovaWorks"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drugs in Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071907436","display_name":"Lawrence F. Eichenfield","orcid":"https://orcid.org/0000-0002-2760-0474","observed_orcids":["https://orcid.org/0000-0002-2760-0474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Eichenfield","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055110526","display_name":"Pearl C. Kwong","orcid":"https://orcid.org/0000-0002-3121-420X","observed_orcids":["https://orcid.org/0000-0002-3121-420X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pearl Kwong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Stephanie Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113008274","display_name":"Daniel P. Krowchuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Krowchuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015808449","display_name":"Krysten Lisella Arekapudi","orcid":"https://orcid.org/0000-0001-5905-2030","observed_orcids":["https://orcid.org/0000-0001-5905-2030"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krysten Arekapudi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081828039","display_name":"Adelaide Ann Hebert","orcid":"https://orcid.org/0000-0002-9167-5729","observed_orcids":["https://orcid.org/0000-0002-9167-5729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adelaide Hebert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6031,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.89264097,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"21","issue":"6","first_page":"582","last_page":"586"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.8349999785423279},{"id":"https://openalex.org/keywords/adolescent-acne","display_name":"adolescent acne","score":0.9390000104904175},{"id":"https://openalex.org/keywords/trifarotene","display_name":"trifarotene","score":0.843999981880188},{"id":"https://openalex.org/keywords/topical-retinoids","display_name":"topical retinoids","score":0.7940000295639038},{"id":"https://openalex.org/keywords/facial-acne","display_name":"facial acne","score":0.765999972820282},{"id":"https://openalex.org/keywords/truncal-acne","display_name":"truncal acne","score":0.8709999918937683},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6340000033378601},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7710000276565552},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.5559999942779541},{"id":"https://openalex.org/keywords/once-daily-application","display_name":"once-daily application","score":0.7680000066757202},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.3370000123977661}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9833999276161194},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.9329672455787659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9223455190658569},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5802115201950073},{"id":"https://openalex.org/C2781197403","wikidata":"https://www.wikidata.org/wiki/Q193472","display_name":"Trunk","level":2,"score":0.5451549291610718},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42177531123161316},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.4177652597427368},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4049846827983856},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2222258746623993},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063465","descriptor_name":"Skin Cream","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D063465","descriptor_name":"Skin Cream","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.36849/jdd.6778","doi":"https://doi.org/10.36849/jdd.6778","is_oa":false,"landing_page_url":"https://doi.org/10.36849/jdd.6778","pdf_url":null,"source":{"id":"https://openalex.org/S111565304","display_name":"Journal of Drugs in Dermatology","issn_l":"1545-9616","issn":["1545-9616"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4323285840","host_organization_name":"SanovaWorks","host_organization_lineage":["https://openalex.org/P4323285840"],"host_organization_lineage_names":["SanovaWorks"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drugs in Dermatology","raw_type":"journal-article"},{"id":"pmid:35674762","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35674762","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2917427088","https://openalex.org/W2959451193","https://openalex.org/W4239034438","https://openalex.org/W3036553864","https://openalex.org/W3110017495","https://openalex.org/W3023223971","https://openalex.org/W7167499200","https://openalex.org/W4400274094","https://openalex.org/W7203621862","https://openalex.org/W3184735587"],"abstract_inverted_index":{"PURPOSE:":[0],"Acne":[1],"vulgaris":[2],"is":[3,12],"very":[4],"common":[5],"among":[6],"adolescents":[7],"and":[8,30,54,70,77,90,96,110,118],"young":[9],"adults.":[10],"It":[11],"important":[13],"for":[14,28,116],"clinicians":[15],"who":[16],"provide":[17],"care":[18],"to":[19,22,63,127],"these":[20],"patients":[21,80],"have":[23],"a":[24,88],"plan":[25],"of":[26,39,46,59,93,122],"action":[27],"assessing":[29],"managing":[31],"acne":[32],"in":[33,56,79],"daily":[34],"practice.":[35],"METHODS:":[36],"Post-hoc":[37],"analysis":[38],"two":[40],"large-scale":[41],"phase":[42],"3":[43],"pivotal":[44],"trials":[45],"trifarotene":[47,123],"0.005%":[48],"cream,":[49],"focusing":[50],"on":[51,73,129],"efficacy,":[52,108],"safety,":[53,109],"tolerability":[55,97],"the":[57,75,119,135],"subgroup":[58],"subjects":[60],"aged":[61],"12":[62],"17,":[64],"inclusive.":[65],"RESULTS:":[66],"Trifarotene":[67,101],"was":[68,87,98,103],"effective":[69],"well":[71],"tolerated":[72],"both":[74],"face":[76],"trunk":[78],"ages":[81],"12-17":[82],"with":[83,105],"moderate":[84],"acne.":[85],"There":[86],"low":[89,120],"acceptable":[91],"rate":[92],"adverse":[94],"events":[95],"favorable.":[99],"CONCLUSIONS:":[100],"monotherapy":[102],"associated":[104],"good":[106],"clinical":[107],"tolerability.":[111],"Once-daily":[112],"application":[113],"offers":[114],"convenience":[115],"patients,":[117],"concentration":[121],"makes":[124],"it":[125],"well-suited":[126],"use":[128],"large":[130],"skin":[131],"areas":[132],"such":[133],"as":[134],"trunk.":[136],"J":[137],"Drugs":[138],"Dermatol.":[139],"2022;21(6):582-586.":[140],"doi:10.36849/JDD.6778.":[141]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-16T00:00:00"}